Xcout Intel
Moleculera Labs
Moleculera BioSciences is a precision medicine company dedicated to transforming patient care. The company develops next-generation diagnostic and predictive treatment algorithms for neurological and psychiatric conditions.
Subscribe to see Moleculera Labs’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Moleculera Labs at a glance
Moleculera Labs is a biotechnology company headquartered in United States. It has raised at least $2.9M across the 2 funding rounds on record. Its most recent funding round raised $1.1M in May 2015. Xcout tracks 6 named people at Moleculera Labs, including Fred Hiller (Chief Financial Officer (Consultant)).
Moleculera Labs leadership
- Fred HillerChief Financial Officer (Consultant)
- Craig ShimasakiCo-Founder, President and CEO
- Madeleine CunninghamCo-Founder, Chief Scientific Officer (Consultant)
- James ApplemanVP Clinical Research & Development
- Joseph M. QuashnockClinical Laboratory Director
- Sean McCormickDirector of Medical Affairs (Consultant)
Moleculera Labs funding rounds
At least $2.9M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| — | $1.1M | 2 named | |
| — | $1.8M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Moleculera Labs competitors
A few of Moleculera Labs's closest competitors — see the full list of competitors and alternatives →
Genetika Plus (now known as NeuroKaire) focuses on transforming depression medication selection by addressing conditions like depression affecting millions worldwide, and collaborates on biopharma trials.
Predicta Biosciences is a precision oncology company that builds a molecular insights platform for blood cancer care. By utilizing a single blood sample, the company integrates multiomics and liquid biopsies to generate longitudinal genomic and immune insights for diagnostics.
Athena Diagnostics provides specialized diagnostic and genetic testing services focusing on neurological diseases, neuromuscular disorders, and developmental disorders such as Alzheimer's disease and muscular dystrophy. The company serves patients and healthcare providers by offering test catalogs, sample collection kits, requisition resources, and billing support.
Durin Life Sciences develops Duritect™, a blood-based test that combines autoantibody biomarkers with machine learning technology to assess patients' risk of having Alzheimer's disease or Parkinson's disease. The company provides laboratory analysis services to process these blood samples and deliver risk score reports to physicians and patients.
Mapmygenome is a molecular diagnostics company that provides personalized DNA, microbiome, and epigenome testing services for health and wellness.
Centogene provides precision medicine solutions through advanced diagnostics, multiomic testing, and bioinformatics platforms. The company serves physicians, patients, and pharmaceutical partners by offering genomic sequencing, biomarker testing, and data-driven insights to accelerate rare disease diagnosis, drug discovery, and personalized therapies.
Get Moleculera Labs's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Moleculera Labs in Xcout Intel
- 6 named people with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access